nimesulide has been researched along with Alloxan Diabetes in 6 studies
nimesulide: structure
nimesulide : An aromatic ether having phenyl and 2-methylsulfonamido-5-nitrophenyl as the two aryl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The main objective of the study was to determine the neuroprotective effect of allopurinol and nimesulide against the cerebral ischemic reperfusion injury in diabetic and nondiabetic rats." | 7.79 | Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats. ( Ansari, MA; Goli, D; Hussain, SK; Mudagal, MP, 2013) |
| "The main objective of the study was to determine the neuroprotective effect of allopurinol and nimesulide against the cerebral ischemic reperfusion injury in diabetic and nondiabetic rats." | 3.79 | Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats. ( Ansari, MA; Goli, D; Hussain, SK; Mudagal, MP, 2013) |
| "Treatment with rutin (100 and 200 mg/kg) and nimesulide (5 and 10 mg/kg) significantly attenuates these alterations as compared to DN control rats." | 1.48 | Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway. ( Bishnoi, M; Kumar, A; Mittal, R; Nag, TC; Singh, DP, 2018) |
| "Nimesulide treatment did not cause any significant change in any of the measured hemodynamic parameters." | 1.35 | Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats. ( Abdelrahman, AM; Al Suleimani, YM, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, Y | 2 |
| Wu, Y | 1 |
| Long, L | 1 |
| Yang, L | 1 |
| Fu, D | 1 |
| Hu, C | 1 |
| Kong, Q | 1 |
| Mittal, R | 1 |
| Kumar, A | 1 |
| Singh, DP | 1 |
| Bishnoi, M | 1 |
| Nag, TC | 1 |
| Leung, JY | 1 |
| Pang, CC | 1 |
| Abdelrahman, AM | 1 |
| Al Suleimani, YM | 1 |
| Yesilot, S | 1 |
| Ozer, MK | 1 |
| Bayram, D | 1 |
| Oncu, M | 1 |
| Karabacak, HI | 1 |
| Cicek, E | 1 |
| Ansari, MA | 1 |
| Hussain, SK | 1 |
| Mudagal, MP | 1 |
| Goli, D | 1 |
6 other studies available for nimesulide and Alloxan Diabetes
| Article | Year |
|---|---|
Inflammation-Responsive Drug-Loaded Hydrogels with Sequential Hemostasis, Antibacterial, and Anti-Inflammatory Behavior for Chronically Infected Diabetic Wound Treatment.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Boronic Acids; Diabetes Mellitus, Experime | 2021 |
Ameliorative potential of rutin in combination with nimesulide in STZ model of diabetic neuropathy: targeting Nrf2/HO-1/NF-kB and COX signalling pathway.
Topics: Animals; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Diabetes Mellitus, Experimental; Diabetic Neur | 2018 |
Effects of nimesulide, a selective COX-2 inhibitor, on cardiovascular function in 2 rat models of diabetes.
Topics: Animals; Arterial Pressure; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Experimental; Epinephrin | 2014 |
Four-week administration of nimesulide, a cyclooxygenase-2 inhibitor, improves endothelial dysfunction in the hindlimb vasculature of streptozotocin-induced diabetic rats.
Topics: Animals; Blood Pressure; Body Weight; Cyclooxygenase 2 Inhibitors; Diabetes Mellitus, Experimental; | 2008 |
Effects of aspirin and nimesulide on tissue damage in diabetic rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Catalase; Diabetes Mellitus, Experimental | 2010 |
Neuroprotective effect of allopurinol and nimesulide against cerebral ischemic reperfusion injury in diabetic rats.
Topics: Allopurinol; Animals; Brain Ischemia; Catalase; Diabetes Mellitus, Experimental; Female; Male; Neuro | 2013 |